Pancreatic & Gallbladder Cancer
Advanced care with multidisciplinary treatment planning for pancreatic and biliary cancers.
Overview
Pancreatic and gallbladder (biliary tract) cancers are among the most challenging malignancies to treat, but advances in chemotherapy combinations, targeted therapies, and clinical trials are improving outcomes.
Our medical oncologists work closely with surgeons, interventional radiologists, and palliative care specialists to provide comprehensive treatment at every stage of disease.
Symptoms & Warning Signs
- Jaundice (yellowing of skin and eyes)
- Abdominal or back pain
- Unexplained weight loss
- Loss of appetite
- New-onset diabetes
- Dark urine or pale stools
Diagnosis & Evaluation
Imaging
CT, MRI/MRCP, and EUS
Biopsy
EUS-guided FNA or core biopsy
Molecular Testing
BRCA, NTRK, MSI, TMB
CA 19-9 Monitoring
Tumor marker tracking
Treatment Options
Frequently Asked Questions
Is pancreatic cancer treatable?
While pancreatic cancer remains challenging, modern chemotherapy regimens and clinical trials have improved survival. Some patients with resectable tumors achieve long-term remission after surgery and adjuvant therapy.
What role does genetic testing play?
Up to 10% of pancreatic cancers have actionable mutations like BRCA. Germline and somatic testing can identify patients eligible for PARP inhibitors and other targeted therapies.
